Davis, Kenneth L.

A new rating scale for Alzheimer's disease

Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984) · American Journal of Psychiatry

Dementia and Cognitive Impairment ResearchPsychological Testing and Assessment

Cited by 4,175

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

Trubetskoy, V., Pardiñas, A. F., Qi, T., Panagiotaropoulou, G., Awasthi, S., Bigdeli, T. B., Bryois, J., Chen, C.-Y., Dennison, C. A., Hall, L. S., et al. (2022) · Nature

Schizophrenia research and treatmentGenetic Associations and Epidemiology

Cited by 2,964

Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores

Vilhjálmsson, B. J., Yang, J., Finucane, H. K., Gusev, A., Lindström, S., Ripke, S., Genovese, G., Loh, P.-R., Bhatia, G., Do, R., et al. (2015) · The American Journal of Human Genetics

Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals

Cited by 1,303

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 1,192

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

Marshall, C. R., Howrigan, D. P., Merico, D., Thiruvahindrapuram, B., Wu, W., Greer, D. S., Antaki, D., Shetty, A., Holmans, P. A., Pinto, D., et al. (2017) · Nature Genetics

Genomic variations and chromosomal abnormalitiesSchizophrenia research and treatment

Cited by 1,058

White Matter Changes in Schizophrenia: Evidence for Myelin-Related Dysfunction

Davis, K. L., Stewart, D. G., Friedman, J. I., Buchsbaum, M., Harvey, P. D., Hof, P. R., Buxbaum, J., & Haroutunian, V. (2003) · Archives of General Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 793

A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease

Davis, K. L., Thal, L. J., Gamzu, E. R., Davis, C. S., Woolson, R. F., Gracon, S. I., Drachman, D. A., Schneider, L. S., Whitehouse, P. J., Hoover, T. M., et al. (1992) · New England Journal of Medicine

Cholinesterase and Neurodegenerative DiseasesDementia and Cognitive Impairment Research

Cited by 626

Partitioning Heritability of Regulatory and Cell-Type-Specific Variants across 11 Common Diseases

Gusev, A., Lee, S. H., Trynka, G., Finucane, H., Vilhjálmsson, B. J., Xu, H., Zang, C., Ripke, S., Bulik-Sullivan, B., Stahl, E., et al. (2014) · The American Journal of Human Genetics

Genetic Associations and EpidemiologyGenomics and Chromatin Dynamics

Cited by 544

Neocortical Neurofibrillary Tangles Correlate With Dementia Severity in Alzheimer's Disease

Bierer, L. M., Hof, P. R., Purohit, D. P., Carlin, L., Schmeidler, J., Davis, K. L., & Perl, D. P. (1995) · Archives of Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 514

A randomized controlled trial of prednisone in Alzheimer’s disease

Aisen, P. S., Davis, K. L., Berg, J. D., Schafer, K., Campbell, K., Thomas, R. G., Weiner, M. F., Farlow, M. R., Sano, M., Grundman, M., et al. (2000) · Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 464

Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia

Hof, P. R., Haroutunian, V., Friedrich, V. L., Byne, W., Buitron, C., Perl, D. P., & Davis, K. L. (2003) · Biological Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 433

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration

Stern, R. G., Mohs, R. C., Davidson, M. H., Schmeidler, J., Silverman, J. M., Kramer‐Ginsberg, E., Searcey, T., Bierer, L. M., & Davis, K. L. (1994) · American Journal of Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 408

Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia

Takahashi, N., Sakurai, T., Davis, K. L., & Buxbaum, J. D. (2011) · Progress in Neurobiology

Schizophrenia research and treatmentNeurogenesis and neuroplasticity mechanisms

Cited by 337

Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease

Haroutunian, V., Purohit, D. P., Perl, D. P., Marin, D., Khan, K., Lantz, M., Davis, K. L., & Mohs, R. C. (1999) · Archives of Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 201

Molecular and Cellular Evidence for an Oligodendrocyte Abnormality in Schizophrenia

Hof, P. R., Haroutunian, V., Copland, C., Davis, K. L., & Buxbaum, J. D. (2002) · Neurochemical Research

Schizophrenia research and treatmentNeurogenesis and neuroplasticity mechanisms

Cited by 199

Alzheimer Disease and Related Neurodegenerative Diseases in Elderly Patients With Schizophrenia: A Postmortem Neuropathologic Study of 100 Cases

Purohit, D. P., Perl, D. P., Haroutunian, V., Powchik, P., Davidson, M., & Davis, K. L. (1998) · Archives of General Psychiatry

Dementia and Cognitive Impairment ResearchSchizophrenia research and treatment

Cited by 185

Tacrine

Davis, K. L., & Powchick, P. (1995) · The Lancet

Cholinesterase and Neurodegenerative DiseasesAlzheimer's disease research and treatments

Cited by 177

Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia

Gupta, D. S., McCullumsmith, R. E., Beneyto, M., Haroutunian, V., Davis, K. L., & Meador‐Woodruff, J. H. (2005) · Synapse

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 146

Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia

Martin-Ruiz, C. M., Haroutunian, V. H., Long, P., Young, A. H., Davis, K. L., Perry, E. K., & Court, J. A. (2003) · Biological Psychiatry

Nicotinic Acetylcholine Receptors StudySchizophrenia research and treatment

Cited by 100

A System-Level Transcriptomic Analysis of Schizophrenia Using Postmortem Brain Tissue Samples

Roussos, P., Katsel, P., Davis, K. L., Siever, L. J., & Haroutunian, V. (2012) · Archives of General Psychiatry

Schizophrenia research and treatmentBioinformatics and Genomic Networks

Cited by 92

Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene

Buxbaum, J. D., Georgieva, L., Young, J. J., Plescia, C., Kajiwara, Y., Jiang, Y., Moskvina, V, Norton, N., Peirce, T., Williams, H., et al. (2008) · Molecular Psychiatry

Schizophrenia research and treatmentProtein Tyrosine Phosphatases

Cited by 86

Localized cortical chronic traumatic encephalopathy pathology after single, severe axonal injury in human brain

Shively, S. B., Edgerton, S. L., Iacono, D., Purohit, D. P., Qu, B.-X., Haroutunian, V., Davis, K. L., Diaz-Arrastia, R., & Perl, D. P. (2017) · Acta Neuropathologica

Traumatic Brain Injury ResearchTraumatic Brain Injury and Neurovascular Disturbances

Cited by 52

Cortical and Subcortical Cognitive Deficits in Schizophrenia: Convergence of Classifications Based on Language and Memory Skill Areas

Harvey, P. D., Moriarty, P. J., Bowie, C., Friedman, J. I., Parrella, M., White, L., & Davis, K. L. (2002) · Journal of Clinical and Experimental Neuropsychology

Schizophrenia research and treatmentDementia and Cognitive Impairment Research

Cited by 18

Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial

Aisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 5